Zenotech Laboratories Limited (BOM:532039)
India · Delayed Price · Currency is INR 39.00
+0.73 (1.91%)
At close: Nov 9, 2026
Zenotech Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 364.19 | 395.62 | 389.76 | 367.62 | 383.53 | 324.94 |
Other Revenue | 6.01 | 6.01 | 1.23 | 0.47 | 6.56 | 4.53 |
| 370.2 | 401.63 | 390.98 | 368.09 | 390.09 | 329.47 | |
Revenue Growth | -8.20% | 2.72% | 6.22% | -5.64% | 18.40% | 69.51% |
Cost of Revenue | 35.48 | 35.48 | 43.24 | 30.89 | 29.34 | 30.48 |
Gross Profit | 334.72 | 366.15 | 347.75 | 337.2 | 360.75 | 298.98 |
Selling, General & Admin | 178.19 | 155.5 | 124 | 94.82 | 78.99 | 71.18 |
Other Operating Expenses | 117 | 111.96 | 80.55 | 69.29 | 68.15 | 48.64 |
Operating Expenses | 367.95 | 338.59 | 274.14 | 234.97 | 218.87 | 189.56 |
Operating Income | -33.23 | 27.56 | 73.61 | 102.23 | 141.88 | 109.43 |
Interest Expense | - | - | - | - | -1.12 | -12.15 |
Interest & Investment Income | 16.65 | 16.65 | 14.09 | 9.45 | 3.69 | 0.99 |
Currency Exchange Gain (Loss) | -0.79 | -0.79 | -0.18 | 0.05 | -0.01 | -0.03 |
Other Non Operating Income (Expenses) | -4.29 | - | - | - | - | - |
EBT Excluding Unusual Items | -21.66 | 43.41 | 87.52 | 111.74 | 144.44 | 98.23 |
Gain (Loss) on Sale of Assets | - | - | - | -0.44 | 0.39 | - |
Other Unusual Items | -2.02 | -1.52 | 19.4 | 0.12 | 0.2 | 0.78 |
Pretax Income | -23.68 | 41.89 | 106.92 | 111.41 | 145.02 | 99.01 |
Income Tax Expense | 18.86 | 52.61 | 50.79 | 28.43 | 29.17 | -122.75 |
Net Income | -42.54 | -10.72 | 56.13 | 82.99 | 115.85 | 221.76 |
Net Income to Common | -42.54 | -10.72 | 56.13 | 82.99 | 115.85 | 221.76 |
Net Income Growth | - | - | -32.36% | -28.37% | -47.76% | - |
Shares Outstanding (Basic) | 66 | 61 | 61 | 61 | 61 | 61 |
Shares Outstanding (Diluted) | 66 | 61 | 61 | 61 | 61 | 61 |
Shares Change | 17.81% | - | - | - | - | - |
EPS (Basic) | -0.65 | -0.18 | 0.92 | 1.36 | 1.90 | 3.63 |
EPS (Diluted) | -0.65 | -0.18 | 0.92 | 1.36 | 1.90 | 3.63 |
EPS Growth | - | - | -32.36% | -28.37% | -47.71% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -47.57 | 18.83 | 56.25 | 75.89 | 144.33 | 157.3 |
Free Cash Flow Per Share | -0.72 | 0.31 | 0.92 | 1.24 | 2.37 | 2.58 |
Gross Margin | 90.42% | 91.16% | 88.94% | 91.61% | 92.48% | 90.75% |
Operating Margin | -8.97% | 6.86% | 18.83% | 27.77% | 36.37% | 33.21% |
Profit Margin | -11.49% | -2.67% | 14.36% | 22.55% | 29.70% | 67.31% |
Free Cash Flow Margin | -12.85% | 4.69% | 14.39% | 20.62% | 37.00% | 47.74% |
EBITDA | 39.53 | 98.69 | 143.21 | 173.08 | 213.61 | 179.16 |
EBITDA Margin | 10.68% | 24.57% | 36.63% | 47.02% | 54.76% | 54.38% |
D&A For EBITDA | 72.75 | 71.13 | 69.6 | 70.85 | 71.73 | 69.74 |
EBIT | -33.23 | 27.56 | 73.61 | 102.23 | 141.88 | 109.43 |
EBIT Margin | -8.97% | 6.86% | 18.83% | 27.77% | 36.37% | 33.21% |
Effective Tax Rate | - | 125.59% | 47.50% | 25.52% | 20.11% | - |
Revenue as Reported | 423.74 | 459.23 | 445.96 | 418.37 | 435.08 | 371.94 |
Advertising Expenses | - | 0.22 | 0.22 | 0.18 | 0.23 | 0.23 |